Literature DB >> 19601604

Gaussia luciferase variant for high-throughput functional screening applications.

Casey A Maguire1, Nikolaos C Deliolanis, Lisa Pike, Johanna M Niers, Lee-Ann Tjon-Kon-Fat, Miguel Sena-Esteves, Bakhos A Tannous.   

Abstract

Gaussia luciferase (Gluc) is a sensitive reporter for studying different biological processes such as gene expression, promoter activity, protein-protein interactions, signal transduction, as well as tumor cell growth and response to therapy. Since Gluc is naturally secreted, the kinetics of these processes can be monitored in real-time by measuring an aliquot of conditioned medium in culture or a few microliters of blood in vivo at different time points. Gluc catalyzes light emission with a short half-life which is unfavorable for certain applications. We isolated a Gluc mutant that catalyzes enhanced light stability in the presence of a detergent, in combination with high sensitivity, making it an attractive luciferase for high-throughput functional screening applications.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19601604      PMCID: PMC2846205          DOI: 10.1021/ac901234r

Source DB:  PubMed          Journal:  Anal Chem        ISSN: 0003-2700            Impact factor:   6.986


  21 in total

Review 1.  Molecular imaging in living subjects: seeing fundamental biological processes in a new light.

Authors:  Tarik F Massoud; Sanjiv S Gambhir
Journal:  Genes Dev       Date:  2003-03-01       Impact factor: 11.361

Review 2.  Shedding light onto live molecular targets.

Authors:  Ralph Weissleder; Vasilis Ntziachristos
Journal:  Nat Med       Date:  2003-01       Impact factor: 53.440

Review 3.  It's not just about anatomy: in vivo bioluminescence imaging as an eyepiece into biology.

Authors:  Christopher H Contag; Brian D Ross
Journal:  J Magn Reson Imaging       Date:  2002-10       Impact factor: 4.813

Review 4.  Spying on cancer: molecular imaging in vivo with genetically encoded reporters.

Authors:  Shimon Gross; David Piwnica-Worms
Journal:  Cancer Cell       Date:  2005-01       Impact factor: 31.743

5.  Codon-optimized Gaussia luciferase cDNA for mammalian gene expression in culture and in vivo.

Authors:  Bakhos A Tannous; Dong-Eog Kim; Juliet L Fernandez; Ralph Weissleder; Xandra O Breakefield
Journal:  Mol Ther       Date:  2005-03       Impact factor: 11.454

6.  Optical imaging of Renilla luciferase reporter gene expression in living mice.

Authors:  S Bhaumik; S S Gambhir
Journal:  Proc Natl Acad Sci U S A       Date:  2001-12-18       Impact factor: 11.205

7.  Rapid evolution of a protein in vitro by DNA shuffling.

Authors:  W P Stemmer
Journal:  Nature       Date:  1994-08-04       Impact factor: 49.962

8.  Recombinant Gaussia luciferase. Overexpression, purification, and analytical application of a bioluminescent reporter for DNA hybridization.

Authors:  Monique Verhaegent; Theodore K Christopoulos
Journal:  Anal Chem       Date:  2002-09-01       Impact factor: 6.986

9.  Cloning of firefly luciferase cDNA and the expression of active luciferase in Escherichia coli.

Authors:  J R de Wet; K V Wood; D R Helinski; M DeLuca
Journal:  Proc Natl Acad Sci U S A       Date:  1985-12       Impact factor: 11.205

10.  A pathway sensor for genome-wide screens of intracellular proteolytic cleavage.

Authors:  Robin Ketteler; Zairen Sun; Karl F Kovacs; Wei-Wu He; Brian Seed
Journal:  Genome Biol       Date:  2008-04-03       Impact factor: 13.583

View more
  35 in total

1.  A water-soluble coelenterazine for sensitive in vivo imaging of coelenterate luciferases.

Authors:  Danielle Morse; Bakhos A Tannous
Journal:  Mol Ther       Date:  2012-04       Impact factor: 11.454

2.  Functional drug screening assay reveals potential glioma therapeutics.

Authors:  Christian E Badr; Thomas Wurdinger; Bakhos A Tannous
Journal:  Assay Drug Dev Technol       Date:  2010-12-27       Impact factor: 1.738

3.  Lanatoside C sensitizes glioblastoma cells to tumor necrosis factor-related apoptosis-inducing ligand and induces an alternative cell death pathway.

Authors:  Christian E Badr; Thomas Wurdinger; Jonas Nilsson; Johanna M Niers; Michael Whalen; Alexei Degterev; Bakhos A Tannous
Journal:  Neuro Oncol       Date:  2011-07-13       Impact factor: 12.300

4.  Multimodal in vivo imaging and blood monitoring of intrinsic and extrinsic apoptosis.

Authors:  Johanna M Niers; Mariam Kerami; Lisa Pike; Grant Lewandrowski; Bakhos A Tannous
Journal:  Mol Ther       Date:  2011-02-22       Impact factor: 11.454

Review 5.  In vivo cell tracking with bioluminescence imaging.

Authors:  Jung Eun Kim; Senthilkumar Kalimuthu; Byeong-Cheol Ahn
Journal:  Nucl Med Mol Imaging       Date:  2014-11-26

6.  One-Step Ultrasensitive Bioluminescent Enzyme Immunoassay Based on Nanobody/Nanoluciferase Fusion for Detection of Aflatoxin B1 in Cereal.

Authors:  Wenjie Ren; Zhenfeng Li; Yang Xu; Debin Wan; Bogdan Barnych; Yanping Li; Zhui Tu; Qinghua He; Jinheng Fu; Bruce D Hammock
Journal:  J Agric Food Chem       Date:  2019-04-24       Impact factor: 5.279

7.  A high-throughput cell-based Gaussia luciferase reporter assay for identifying modulators of fibulin-3 secretion.

Authors:  John D Hulleman; Steven J Brown; Hugh Rosen; Jeffery W Kelly
Journal:  J Biomol Screen       Date:  2012-12-10

8.  Translational attenuation differentially alters the fate of disease-associated fibulin proteins.

Authors:  John D Hulleman; William E Balch; Jeffery W Kelly
Journal:  FASEB J       Date:  2012-08-07       Impact factor: 5.191

Review 9.  Secreted blood reporters: insights and applications.

Authors:  Bakhos A Tannous; Jian Teng
Journal:  Biotechnol Adv       Date:  2011-09-08       Impact factor: 14.227

10.  Directed molecular evolution reveals Gaussia luciferase variants with enhanced light output stability.

Authors:  M Hannah Degeling; M Sarah S Bovenberg; Grant K Lewandrowski; Mark C de Gooijer; Carmen L A Vleggeert-Lankamp; Marie Tannous; Casey A Maguire; Bakhos A Tannous
Journal:  Anal Chem       Date:  2013-02-20       Impact factor: 6.986

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.